Daxymia 100 (Imatinib 100 mg)

Daxymia-100 (Imatinib 100 mg) is a targeted therapy used to treat certain types of cancer particularly chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). This tyrosine kinase inhibitor works by blocking specific signals that promote the growth and division of cancer cells effectively halting disease progression. Daxymia-100 has revolutionized the treatment of these conditions offering patients improved survival rates and a better quality of life.